Use of a Hypertension Tool to Manage Blood Pressure in Hemodialysis

The objective of this project is to develop, validate, and implement a tool to help manager hypertension in patients on hemodialysis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Toronto General Hospital

Toronto, Ontario, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

≥ 18 years of age
Receiving in-centre HD for at least 3 months
Considered hypertensive based on a median intradialytic blood pressure ≥ 140/90 mmgHG

Exclusion criteria

Are unable to provide informed consent
Are deemed medically unstable by the primary physician

Treatment and study plan

Hypertension tool

Other

An algorithm developed by staff at UHN to help manage hypertension in hemodialysis patients.

Primary outcomes

Blood pressure

Time frame: 3 months

Sponsors and collaborators

Lead sponsor

University Health Network, Toronto

Other

Registry information

Official study title

Development, Validation, and Implementation of a Clinical Decision Tool for Blood Pressure Management in Patients on Hemodialysis

Important dates

Study start: 2016
Primary completion: 2021
Study completion: 2021
First posted: Mar 24, 2017
Registry last updated: May 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed